Carotid Stent, AAA Market Entry: Boston Scientific Moves On Earn-Outs

Boston Scientific intends to acquire carotid stent manufacturer EndoTex by year-end, following an anticipated FDA approval of NexStent

More from Archive

More from Medtech Insight